Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
2/5 New draft guidance outlines ways for drug developers to consider measuring/demonstrating the effectiveness and benefits of new or existing MAT products. Today’s guidance is part of #FDA’s ongoing commitment to promote more widespread development, access to and adoption of MAT
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.